Nifty
Sensex
:
:
15097.35
51039.31
115.35 (0.77%)
387.85 (0.77%)

Pharmaceuticals & Drugs - Global

Rating :
41/99

BSE: 532872 | NSE: SPARC

168.30
25-Feb-2021
  • Open
  • High
  • Low
  • Previous Close
  •  170.00
  •  170.40
  •  167.50
  •  169.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  759964
  •  1284.03
  •  209.70
  •  81.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,443.02
  • N/A
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,510.90
  • N/A
  • -97.78

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.46%
  • 5.59%
  • 17.18%
  • FII
  • DII
  • Others
  • 3.06%
  • 0.01%
  • 5.70%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.79
  • -13.79
  • -0.62

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 46.89
  • 37.45
  • 5.03

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 43.39
  • 34.88
  • 16.61

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -35.06
  • -35.06
  • -35.06

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.93
  • -38.72
  • -28.69

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

News Update:


  • Sun Pharma initiates Phase 2 clinical trial for SCD-044 in patients
    5th Jan 2021, 09:12 AM

    The study will enroll approximately 240 subjects and top line results are expected in 2022

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.